Page 2 - Juan Carlos Jaen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Juan carlos jaen. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Juan Carlos Jaen Today - Breaking & Trending Today

Arcus Biosciences (NYSE:RCUS) Shares Down 7.8%

Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating) traded down 7.8% on Tuesday . The stock traded as low as $17.78 and last traded at $17.99. 387,122 shares traded hands during trading, a decline of 61% from the average session volume of 999,097 shares. The stock had previously closed at $19.52. Wall Street Analyst Weigh In […] ....

Jennifer Jarrett , Juan Carlos Jaen , Terryj Rosen , Arcus Biosciences Inc , Vanguard Group Inc , Securities Exchange Commission , Metlife Investment Management , Lazard Asset Management , Dimensional Fund Advisors , Arcus Biosciences , Get Rating , Biosciences Trading Down , Exchange Commission , Life Investment Management , Fund Advisors , Arcus Biosciences Daily , Nyse Rcus ,

Fury Gold Mines Limited (NYSEAMERICAN:FURY) Short Interest Update

Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating)’s share price was down 7.8% during mid-day trading on Tuesday . The company traded as low as $17.78 and last traded at $17.99. Approximately 387,122 shares changed hands during trading, a decline of 61% from the average daily volume of 999,097 shares. The stock had previously closed at […] ....

Terryj Rosen , Juan Carlos Jaen , Jennifer Jarrett , Hermes Inc , Securities Exchange Commission , Arcus Biosciences Inc , Lazard Asset Management , Arcus Biosciences Company Profile , Arcus Biosciences , Get Rating , Biosciences Stock Down , Exchange Commission , Financial Advisors , Arcus Biosciences Daily , Nyse Rcus ,

Wedbush Analysts Cut Earnings Estimates for Arcus Biosciences, Inc. (NYSE:RCUS)

Arcus Biosciences, Inc. (NYSE:RCUS – Get Rating) – Investment analysts at Wedbush dropped their Q2 2023 earnings per share estimates for Arcus Biosciences in a report issued on Wednesday, May 10th. Wedbush analyst R. Driscoll now anticipates that the company will post earnings of ($1.23) per share for the quarter, down from their prior estimate […] ....

Terryj Rosen , Juan Carlos Jaen , Jennifer Jarrett , Arcus Biosciences Company Profile , Charles Schwab Investment Management Inc , Arcus Biosciences Inc , Tejara Capital Ltd , Securities Exchange Commission , Panagora Asset Management Inc , Platinum Investment Management Ltd , Profund Advisors , Arcus Biosciences , Get Rating , Arcus Bioscience , Biosciences Trading Down , Asset Management , Capital Ltd , Schwab Investment Management , Platinum Investment Management , Investment Management , Exchange Commission , Arcus Biosciences Daily , Nyse Rcus , Earnings Estimates ,

Arcus Biosciences (NYSE:RCUS) Releases Quarterly Earnings Results, Misses Expectations By $0.03 EPS

Arcus Biosciences (NYSE:RCUS – Get Rating) posted its quarterly earnings data on Tuesday. The company reported ($1.09) earnings per share for the quarter, missing the consensus estimate of ($1.06) by ($0.03), Briefing.com reports. The firm had revenue of $25.00 million for the quarter, compared to analyst estimates of $22.47 million. Arcus Biosciences had a negative […] ....

United States , Juan Carlos Jaen , Jennifer Jarrett , Terryj Rosen , Voya Investment Management , Arcus Biosciences Inc , Tennessee Treasury Department , Kiwi Wealth Investments Limited Partnership , Arcus Biosciences , Get Rating , Biosciences Stock Down , Investment Management , Arcus Biosciences Daily , Nyse Rcus ,

Arcus Biosciences (NYSE:RCUS) Issues Earnings Results, Misses Expectations By $0.03 EPS

Arcus Biosciences (NYSE:RCUS – Get Rating) issued its quarterly earnings data on Tuesday. The company reported ($1.09) EPS for the quarter, missing analysts’ consensus estimates of ($1.06) by ($0.03), Briefing.com reports. The business had revenue of $25.00 million during the quarter, compared to analyst estimates of $22.47 million. Arcus Biosciences had a negative net margin […] ....

Terryj Rosen , Jennifer Jarrett , Juan Carlos Jaen , Northern Trust Corp , Vanguard Group Inc , Goldman Sachs Group Inc , Geode Capital Management , Securities Exchange Commission , Arcus Biosciences Company Profile , Arcus Biosciences Inc , Arcus Biosciences , Get Rating , Exchange Commission , Street Corp , Sachs Group , Capital Management , Trust Corp , Arcus Biosciences Daily , Nyse Rcus ,